Last reviewed · How we verify
Octreotide Acetate Microspheres for Injection injection — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Octreotide Acetate Microspheres for Injection injection (Octreotide Acetate Microspheres for Injection injection) — CSPC ZhongQi Pharmaceutical Technology Co., Ltd..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Octreotide Acetate Microspheres for Injection injection TARGET | Octreotide Acetate Microspheres for Injection injection | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Octreotide Acetate Microspheres for Injection injection CI watch — RSS
- Octreotide Acetate Microspheres for Injection injection CI watch — Atom
- Octreotide Acetate Microspheres for Injection injection CI watch — JSON
- Octreotide Acetate Microspheres for Injection injection alone — RSS
Cite this brief
Drug Landscape (2026). Octreotide Acetate Microspheres for Injection injection — Competitive Intelligence Brief. https://druglandscape.com/ci/octreotide-acetate-microspheres-for-injection-injection. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab